Riordan, Lewis & Haden exits Cymetrix in $75m deal


exitPrivate equity firm Riordan, Lewis & Haden (RLH) has exited its investment in revenue cycle management business Cymetrix Corporation, which was sold to Navigant for $75m.

Under the terms of the deal, Navigant could pay a further $25m if the company meets certain performance milestones.

Cymetrix, which was launched in 2001, provides its revenue cycle management software to healthcare organizations and hospital-affiliated physician practices.

RLH targets companies with revenues of $25m to $150m in the business services, healthcare, and government services sectors and currently has $600m of commitments under management.

Copyright © 2014 AltAssets